MK-5108 Size:Solid 2 mg The combination produces ~30% complete

The combination produces ~30% complete response rate (CR) in contrast to CPT-11 alone where no CR is found

InChi: InChI=1S/C25H15ClF2N4O2/c26-15-6-9-17-18(10-15)23(21-19(27)2-1-3-20(21)28)29-11-14-12-30-25(32-22(14)17)31-16-7-4-13(5-8-16)24(33)34/h1-10

ABT-888 dihydrochloride (10 μM) suppresses the surviving fraction (SF) by 43% in the clonogenic H1299 cells

9S)-8-methoxy-9-methyl-16-oxo-6

interleukin (IL)-1β

MK-5108 Size:Solid 2 mg The combination produces ~30% completeMK 5108, also known as VX689, is a novel small molecule with potent inhibitory activity against Aurora A kinase. MK 5108 specifically inhibited Aurora A kinase in a panel of protein kinase assays. MK 5108 also induced phosphorylated Histone H3 in skin and xenograft tumor tissues in a nude rat xenograft model. MK 5108 inhibited growth of human tumor cell lines in culture and in different xenograft models. MK 5108 is currently tested in clinical trials